Which companies overlap with Australian and New Zealand Intensive Care Research Centre's portfolio?

Top competitors by shared drug class: Assistance Publique - Hôpitaux de Paris, Alrijne Ziekenhuis Leiderdorp, Amgen, Anemia Working Group Romania, Ain Shams University.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/australian-and-new-zealand-intensive-care-research-centre.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-18 · How we verify

Australian and New Zealand Intensive Care Research Centre — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Australian and New Zealand Intensive Care Research Centre pipeline: 0 marketed, 0 filed, 3 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 3 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Liquid-stored platelets	Liquid-stored platelets	phase 3	Blood product / Cellular therapy		Hematology / Critical Care
Epoetin Alfa 40000 UNT/ML	Epoetin Alfa 40000 UNT/ML	phase 3	Erythropoiesis-stimulating agent (ESA)	Erythropoietin receptor (EPOR)	Hematology
Cryopreserved platelets	Cryopreserved platelets	phase 3	Blood product / Cellular therapy		Hematology / Critical Care

Therapeutic area mix

Hematology / Critical Care · 2
Hematology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Assistance Publique - Hôpitaux de Paris · 2 shared drug classes
Alrijne Ziekenhuis Leiderdorp · 1 shared drug class
Amgen · 1 shared drug class
Anemia Working Group Romania · 1 shared drug class
Ain Shams University · 1 shared drug class
Barts & The London NHS Trust · 1 shared drug class
Bio Sidus SA · 1 shared drug class
Affymax · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Australian and New Zealand Intensive Care Research Centre:

Cite this brief

Drug Landscape (2026). Australian and New Zealand Intensive Care Research Centre — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/australian-and-new-zealand-intensive-care-research-centre. Accessed 2026-05-18.